New aspects of erythropoietin treatment.
Bergström
J
J
D000740:Anemia / Q000503:physiopathology; D000753:Anemia, Refractory / Q000188:drug therapy / Q000209:etiology; D001793:Blood Preservation; D001804:Blood Transfusion, Autologous; D004920:Erythropoiesis; D004921:Erythropoietin / Q000009:adverse effects / Q000096:biosynthesis / Q000502:physiology / Q000627:therapeutic use*; D006402:Hematologic Diseases / Q000188:drug therapy; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D009369:Neoplasms / Q000097:blood / Q000150:complications; D017467:Receptors, Erythropoietin / Q000502:physiology; D011994:Recombinant Proteins / Q000493:pharmacokinetics; D006435:Renal Dialysis
D017467:Receptors, Erythropoietin; D011994:Recombinant Proteins; D004921:Erythropoietin